fosinopril sodium and hydrochlorothiazide tablet
eon labs, inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8) - fosinopril sodium 10 mg
chlorzoxazone tablet
cameron pharmaceuticals - chlorzoxazone (unii: h0de420u8g) (chlorzoxazone - unii:h0de420u8g) - chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of this drug has not been clearly identified, but may be related to its sedative properties. chlorzoxazone does not directly relax tense skeletal muscles in man. chlorzoxazone is contraindicated in patients with known intolerance to the drug.
omisirge- omidubicel-onlv kit
gamida cell inc. - omidubicel (unii: et4jc4s66e) (omidubicel - unii:et4jc4s66e) - omisirge is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy derived from cord blood indicated for use in adults and pediatric patients 12 years and older with hematologic malignancies who are planned for umbilical cord blood transplantation following myeloablative conditioning to reduce the time to neutrophil recovery and the incidence of infection. omisirge is contraindicated in patients with known hypersensitivity to dimethyl sulfoxide (dmso), dextran 40, gentamicin, human serum albumin, or bovine products. risk summary there are no available data with omisirge use in pregnant women. no animal reproductive and developmental toxicity studies have been conducted with omisirge to assess whether it can cause fetal harm when administered to a pregnant woman. omisirge should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. in the united states (u.s.) general population, the estimated background risk of major birth defects and miscarriage in
dextran 70
baxter healthcare limited - dextran 70 glucose - solution for infusion - 6/5 %w/v
dextran 6% in 5% dextrose injection solution
hospira healthcare ulc - dextran; dextrose - solution - 60mg; 50mg - dextran 60mg; dextrose 50mg - replacement preparations
dextran 6% in 0.9% sodium chloride injection solution
hospira healthcare ulc - dextran; sodium chloride - solution - 60mg; 9mg - dextran 60mg; sodium chloride 9mg - replacement preparations
rheomacrodex 10% in saline or dextrose injection
advanced medical optics, inc. (amo) - dextran 40, sodium chloride - injection
rheomacrodex/dextrose solution for infusion 10 %w/v
pharmacia biosystems limited - dextran 40 - solution for infusion - 10 %w/v
rheomacrodex/saline solution for infusion 10 %w/v
pharmacia biosystems limited - dextran 40 - solution for infusion - 10 %w/v
6% dextran 70 in 5% glucose 500ml injection fkb5063g
baxter healthcare pty ltd - glucose monohydrate, quantity: 50 g/l; dextran 70, quantity: 60 g/l - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)